Luis Pizarro directs the Drugs for Neglected Diseases Initiative (DNDi), a non-profit entity that seeks therapies against these ills. “The pharmaceutical industry, which is driven by profit, forgets about them, and so do governments and scientists,” he says.
Luis Pizarro, executive director of DNDi.A. MawaffoDND
Until 2009, the only treatment available for sleeping sickness it was an arsenic-based drug, melarsoprol, which was lethal in one in 20 patients. When receiving the therapy, injectable, the patients assured that it was like s
Get Premium from €1 the first month
Take advantage of this limited time offer and access all web content
